Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-02-15
Reed John C Files Johnson & Johnson (JNJ) Form 4 - February 15, 2026
Reed John C traded 109.7K JNJ shares worth $21.4M in this Form 4 filing, reported to the SEC on 2026-02-15.
- Insider
- Reed John C
- Issuer
- Johnson & Johnson JNJ · NYSE
- Filed
- Period
- 2026-02-15
- Accession
- 0000200406-26-000039
- Source
- Official filing on sec.gov ↗
Transactions (9)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Reed John C | 2026-02-17 | Sell | 2.3K | $243.00 | $554.8K | Direct |
| Reed John C | 2026-02-17 | Buy | 21.7K | $157.92 | $3.4M | Direct |
| Reed John C | 2026-02-17 | Sell | 21.7K | $243.00 | $5.3M | Direct |
| Reed John C | 2026-02-17 | Buy | 29.9K | $156.15 | $4.7M | Direct |
| Reed John C | 2026-02-17 | Sell | 29.9K | $243.00 | $7.3M | Direct |
| Reed John C | 2026-02-15 | Sell | 385 | $243.45 | $93.7K | Direct |
| Reed John C | 2026-02-15 | Buy | 1.8K | $0.00 | $0.00 | Direct |
| Reed John C | 2026-02-15 | Sell | 528 | $243.45 | $128.5K | Direct |
| Reed John C | 2026-02-15 | Buy | 1.3K | $0.00 | $0.00 | Direct |
| Net change | 0 | −$5.2M | ||||
About Johnson & Johnson
Johnson & Johnson is a multinational corporation engaged in the research, development, production, and sale of a broad range of healthcare products. Primarily known for its pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson has a significant presence in the global healthcare industry. It develops medications for a variety of fields such as immunology, oncology, neurology, infectious diseases, and vaccines. The company also produces a wide array of medical devices for surgery, orthopedics, and cardiovascular health. In addition to pharmaceuticals, Johnson & Johnson is renowned for its consumer health products, including baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals, with well-recognized brands like Band-Aid, Tylenol, and Neutrogena. Operating globally, the corporation's extensive portfolio and commitment to healthcare innovation make it a pivotal player in the industry, ensuring it remains influential in addressing worldwide health challenges and advancing medical technology.
Track JNJ insider activity
Get alerted when Johnson & Johnson executives buy or sell their shares.